Achieve Life Sciences, Inc. Debt Securities, Available-for-sale, Amortized Cost
Achieve Life Sciences, Inc. (ACHV) had Debt Securities, Available-for-sale, Amortized Cost of $141.43 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-11
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $141.43M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $10.23M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $15.47M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $16.18M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2026-06-30 | $141.43M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $10.23M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $15.47M 10-K · filed 2026-03-24 | |
| 2025-09-30 | $16.18M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $3.52M 10-Q · filed 2025-08-07 | |
| 2024-12-31 | $21.58M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $10.23M 10-Q · filed 2025-05-13 | $33.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $46.57M 10-Q · filed 2024-08-13 | |
| 2017-03-31 | $760.00K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $10.23M 10-K · filed 2017-02-23 | |
| 2016-09-30 | $12.76M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $29.14M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $27.20M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $20.89M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $23.46M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $12.19M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $15.10M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $19.18M 10-K · filed 2016-03-09 | |
| 2014-09-30 | $5.06M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-07 | |
| 2013-12-31 | $24.63M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |